Krystal Biotech, Inc. (KRYS) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor inKrystal Biotech, Inc. KRYS. The stock has moved higher by 40.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider KRYS’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as KRYS has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Krystal Biotech, Inc. (KRYS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research